Mullins, R., & Chandalia, M
The following GLP-1 (glucagon-like peptide-1) receptor agonists are FDA-approved for weight loss:[ref] Retatrutide is a GLP-1/GIP/GCG triple agonist that is currently in trials for weight loss and diabetes, showing promise for weight loss without muscle loss (2026)
Since Medicaid will usually cover GLP-1s like Ozempic, Mounjaro, and Trulicity for the treatment of health conditions like Type 2 diabetes, you might be wondering if its possible to prescribe these off-label for weight loss and have Medicaid cover them
You didnt start GLP-1 therapy to become a full-time meal-prep strategist
Typically, such medications are kept refrigerated between 2C and 8C (36F to 46F) in their original packaging to protect them from light and contamination
Expanded coverage of GLP-1 medications may cover 10 percent of Medicare beneficiaries